History of methamphetamine use

Among PWID whose main drug was methamphetamine, being in jail in the past year (AOR 2.14, 95% CI 0.98-4.65, p = .056) and having an injection-related infection in the past year (AOR 2.43, 95% CI 0.99-

Effect: null; AOR 2.14; CI: 95% CI: 0.98-4.65

Among PWID whose main drug was methamphetamine, being in jail in the past year (AOR 2.14, 95% CI 0.98-4.65, p = .056) and having an injection-related infection in the past year (AOR 2.43, 95% CI 0.99-

Effect: null; AOR 2.14; CI: 95% CI: 0.98-4.65

Among PWID whose main drug was methamphetamine, being in jail in the past year (AOR 2.14, 95% CI 0.98-4.65, p = .056) and having an injection-related infection in the past year (AOR 2.43, 95% CI 0.99-

Effect: null; AOR 2.14; CI: 95% CI: 0.98-4.65

Among PWID whose main drug was methamphetamine, being in jail in the past year (AOR 2.14, 95% CI 0.98-4.65, p = .056) and having an injection-related infection in the past year (AOR 2.43, 95% CI 0.99-

Effect: null; AOR 2.14; CI: 95% CI: 0.98-4.65

Among PWID whose main drug was methamphetamine, being in jail in the past year (AOR 2.14, 95% CI 0.98-4.65, p = .056) and having an injection-related infection in the past year (AOR 2.43, 95% CI 0.99-

Effect: null; AOR 2.14; CI: 95% CI: 0.98-4.65

Among PWID whose main drug was methamphetamine, being in jail in the past year (AOR 2.14, 95% CI 0.98-4.65, p = .056) and having an injection-related infection in the past year (AOR 2.43, 95% CI 0.99-

Effect: null; AOR 2.14; CI: 95% CI: 0.98-4.65

Among PWID whose main drug was methamphetamine, being in jail in the past year (AOR 2.14, 95% CI 0.98-4.65, p = .056) and having an injection-related infection in the past year (AOR 2.43, 95% CI 0.99-

Effect: null; AOR 2.14; CI: 95% CI: 0.98-4.65

Among PWID whose main drug was methamphetamine, being in jail in the past year (AOR 2.14, 95% CI 0.98-4.65, p = .056) and having an injection-related infection in the past year (AOR 2.43, 95% CI 0.99-

Effect: null; AOR 2.14; CI: 95% CI: 0.98-4.65

Among PWID whose main drug was methamphetamine, being in jail in the past year (AOR 2.14, 95% CI 0.98-4.65, p = .056) and having an injection-related infection in the past year (AOR 2.43, 95% CI 0.99-

Effect: null; AOR 2.14; CI: 95% CI: 0.98-4.65

Among PWID whose main drug was methamphetamine, being in jail in the past year (AOR 2.14, 95% CI 0.98-4.65, p = .056) and having an injection-related infection in the past year (AOR 2.43, 95% CI 0.99-

Effect: null; AOR 2.14; CI: 95% CI: 0.98-4.65

Among PWID whose main drug was methamphetamine, being in jail in the past year (AOR 2.14, 95% CI 0.98-4.65, p = .056) and having an injection-related infection in the past year (AOR 2.43, 95% CI 0.99-

Effect: null; AOR 2.14; CI: 95% CI: 0.98-4.65

Among PWID whose main drug was methamphetamine, being in jail in the past year (AOR 2.14, 95% CI 0.98-4.65, p = .056) and having an injection-related infection in the past year (AOR 2.43, 95% CI 0.99-

Effect: null; AOR 2.14; CI: 95% CI: 0.98-4.65

Among PWID whose main drug was methamphetamine, being in jail in the past year (AOR 2.14, 95% CI 0.98-4.65, p = .056) and having an injection-related infection in the past year (AOR 2.43, 95% CI 0.99-

Effect: null; AOR 2.14; CI: 95% CI: 0.98-4.65

Among PWID whose main drug was methamphetamine, being in jail in the past year (AOR 2.14, 95% CI 0.98-4.65, p = .056) and having an injection-related infection in the past year (AOR 2.43, 95% CI 0.99-

Effect: null; AOR 2.14; CI: 95% CI: 0.98-4.65

Among PWID whose main drug was methamphetamine, being in jail in the past year (AOR 2.14, 95% CI 0.98-4.65, p = .056) and having an injection-related infection in the past year (AOR 2.43, 95% CI 0.99-

Effect: null; AOR 2.14; CI: 95% CI: 0.98-4.65

Among PWID whose main drug was methamphetamine, being in jail in the past year (AOR 2.14, 95% CI 0.98-4.65, p = .056) and having an injection-related infection in the past year (AOR 2.43, 95% CI 0.99-

Effect: null; AOR 2.14; CI: 95% CI: 0.98-4.65

Among PWID whose main drug was methamphetamine, being in jail in the past year (AOR 2.14, 95% CI 0.98-4.65, p = .056) and having an injection-related infection in the past year (AOR 2.43, 95% CI 0.99-

Effect: null; AOR 2.14; CI: 95% CI: 0.98-4.65

Among PWID whose main drug was methamphetamine, being in jail in the past year (AOR 2.14, 95% CI 0.98-4.65, p = .056) and having an injection-related infection in the past year (AOR 2.43, 95% CI 0.99-

Effect: null; AOR 2.14; CI: 95% CI: 0.98-4.65

Among PWID whose main drug was methamphetamine, being in jail in the past year (AOR 2.14, 95% CI 0.98-4.65, p = .056) and having an injection-related infection in the past year (AOR 2.43, 95% CI 0.99-

Effect: null; AOR 2.14; CI: 95% CI: 0.98-4.65

Among PWID whose main drug was methamphetamine, being in jail in the past year (AOR 2.14, 95% CI 0.98-4.65, p = .056) and having an injection-related infection in the past year (AOR 2.43, 95% CI 0.99-

Effect: null; AOR 2.14; CI: 95% CI: 0.98-4.65

Among PWID whose main drug was methamphetamine, being in jail in the past year (AOR 2.14, 95% CI 0.98-4.65, p = .056) and having an injection-related infection in the past year (AOR 2.43, 95% CI 0.99-

Effect: null; AOR 2.14; CI: 95% CI: 0.98-4.65

Among PWID whose main drug was methamphetamine, being in jail in the past year (AOR 2.14, 95% CI 0.98-4.65, p = .056) and having an injection-related infection in the past year (AOR 2.43, 95% CI 0.99-

Effect: null; AOR 2.14; CI: 95% CI: 0.98-4.65

Among PWID whose main drug was methamphetamine, being in jail in the past year (AOR 2.14, 95% CI 0.98-4.65, p = .056) and having an injection-related infection in the past year (AOR 2.43, 95% CI 0.99-

Effect: null; AOR 2.14; CI: 95% CI: 0.98-4.65

Among PWID whose main drug was methamphetamine, being in jail in the past year (AOR 2.14, 95% CI 0.98-4.65, p = .056) and having an injection-related infection in the past year (AOR 2.43, 95% CI 0.99-

Effect: null; AOR 2.14; CI: 95% CI: 0.98-4.65

Among PWID whose main drug was methamphetamine, being in jail in the past year (AOR 2.14, 95% CI 0.98-4.65, p = .056) and having an injection-related infection in the past year (AOR 2.43, 95% CI 0.99-

Effect: null; AOR 2.14; CI: 95% CI: 0.98-4.65

Among PWID whose main drug was methamphetamine, being in jail in the past year (AOR 2.14, 95% CI 0.98-4.65, p = .056) and having an injection-related infection in the past year (AOR 2.43, 95% CI 0.99-

Effect: null; AOR 2.14; CI: 95% CI: 0.98-4.65

Among PWID whose main drug was methamphetamine, being in jail in the past year (AOR 2.14, 95% CI 0.98-4.65, p = .056) and having an injection-related infection in the past year (AOR 2.43, 95% CI 0.99-

Effect: null; AOR 2.14; CI: 95% CI: 0.98-4.65

Among methamphetamine users interested in reducing use, the most common type of help wanted was 1:1 counseling (49%), followed by medications that may help reduce stimulant use (48%).

Effect: improvement; 49%

Among methamphetamine users interested in reducing use, the most common type of help wanted was 1:1 counseling (49%), followed by medications that may help reduce stimulant use (48%).

Effect: improvement; 49%

Among methamphetamine users interested in reducing use, the most common type of help wanted was 1:1 counseling (49%), followed by medications that may help reduce stimulant use (48%).

Effect: improvement; 49%

Among methamphetamine users interested in reducing use, the most common type of help wanted was 1:1 counseling (49%), followed by medications that may help reduce stimulant use (48%).

Effect: improvement; 49%

Among methamphetamine users interested in reducing use, the most common type of help wanted was 1:1 counseling (49%), followed by medications that may help reduce stimulant use (48%).

Effect: improvement; 49%

Among methamphetamine users interested in reducing use, the most common type of help wanted was 1:1 counseling (49%), followed by medications that may help reduce stimulant use (48%).

Effect: improvement; 49%

Among methamphetamine users interested in reducing use, the most common type of help wanted was 1:1 counseling (49%), followed by medications that may help reduce stimulant use (48%).

Effect: improvement; 49%

Among methamphetamine users interested in reducing use, the most common type of help wanted was 1:1 counseling (49%), followed by medications that may help reduce stimulant use (48%).

Effect: improvement; 49%

Among methamphetamine users interested in reducing use, the most common type of help wanted was 1:1 counseling (49%), followed by medications that may help reduce stimulant use (48%).

Effect: improvement; 49%

Among methamphetamine users interested in reducing use, the most common type of help wanted was 1:1 counseling (49%), followed by medications that may help reduce stimulant use (48%).

Effect: improvement; 49%

Among methamphetamine users interested in reducing use, the most common type of help wanted was 1:1 counseling (49%), followed by medications that may help reduce stimulant use (48%).

Effect: improvement; 49%

Among methamphetamine users interested in reducing use, the most common type of help wanted was 1:1 counseling (49%), followed by medications that may help reduce stimulant use (48%).

Effect: improvement; 49%

Among methamphetamine users interested in reducing use, the most common type of help wanted was 1:1 counseling (49%), followed by medications that may help reduce stimulant use (48%).

Effect: improvement; 49%

Among methamphetamine users interested in reducing use, the most common type of help wanted was 1:1 counseling (49%), followed by medications that may help reduce stimulant use (48%).

Effect: improvement; 49%

Among methamphetamine users interested in reducing use, the most common type of help wanted was 1:1 counseling (49%), followed by medications that may help reduce stimulant use (48%).

Effect: improvement; 49%

Among methamphetamine users interested in reducing use, the most common type of help wanted was 1:1 counseling (49%), followed by medications that may help reduce stimulant use (48%).

Effect: improvement; 49%

Among methamphetamine users interested in reducing use, the most common type of help wanted was 1:1 counseling (49%), followed by medications that may help reduce stimulant use (48%).

Effect: improvement; 49%

Among methamphetamine users interested in reducing use, the most common type of help wanted was 1:1 counseling (49%), followed by medications that may help reduce stimulant use (48%).

Effect: improvement; 49%

Among methamphetamine users interested in reducing use, the most common type of help wanted was 1:1 counseling (49%), followed by medications that may help reduce stimulant use (48%).

Effect: improvement; 49%

Among methamphetamine users interested in reducing use, the most common type of help wanted was 1:1 counseling (49%), followed by medications that may help reduce stimulant use (48%).

Effect: improvement; 49%

Among methamphetamine users interested in reducing use, the most common type of help wanted was 1:1 counseling (49%), followed by medications that may help reduce stimulant use (48%).

Effect: improvement; 49%

Among methamphetamine users interested in reducing use, the most common type of help wanted was 1:1 counseling (49%), followed by medications that may help reduce stimulant use (48%).

Effect: improvement; 49%

Among methamphetamine users interested in reducing use, the most common type of help wanted was 1:1 counseling (49%), followed by medications that may help reduce stimulant use (48%).

Effect: improvement; 49%